Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
Simonetti
Giacomo D
GD
Bianchetti
Mario G
MG
Konrad
Martin
M
von Vigier
Rodo O
RO
D000740:Anemia / Q000139:chemically induced* / Q000188:drug therapy; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D000077405:Irbesartan; D007501:Iron / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D009404:Nephrotic Syndrome / Q000601:surgery*; D013777:Tetrazoles / Q000009:adverse effects*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D006454:Hemoglobins; D013777:Tetrazoles; D004921:Erythropoietin; D007501:Iron; D000077405:Irbesartan